article thumbnail

Juno Pharmaceuticals buys Omega Laboratories

Pharmaceutical Technology

Juno Pharmaceuticals Canada has purchased Omega Laboratories, a specialist injectable pharmaceutical manufacturer in Canada, for an undisclosed sum. The merged entity represents one of the biggest specialist generic injectable operations in Canada with local manufacturing facilities.

article thumbnail

Bob Harrell

Pharma Marketing Network

Bob is a life sciences and technology marketing leader with more than 25 years of experience working directly for pharmaceutical manufacturers (Merck, AstraZeneca, and Shire) and for technology companies that serve the industry (Appature, IQVIA, and Sparta). The post Bob Harrell appeared first on Pharma Marketing Network.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Leading patient adherence pharmaceutical companies

Pharmaceutical Technology

Pharmaceutical and healthcare companies are working continuously to improve patient adherence, which also impacts disease control and pharmaceutical industry revenues directly. Many companies use artificial intelligence (AI) to enable pharmaceutical manufacturers to overcome barriers to medication adherence.

Leads 52
article thumbnail

Key developments in pharmaceutical manufacturing – September 2023

European Pharmaceutical Review

September 2023 saw a wave of new pharmaceutical manufacturing facility expansions and launches across Europe. Research by the Confederation of British Industry (CBI) , released in September this year, highlighted progress for UK manufacturing in its latest Industrial Trends Survey. Meath opened last month.

article thumbnail

What factors are driving life sciences FDI in 2022?

Pharmaceutical Technology

Linked to talent, the presence of good universities is another great sign for life sciences, especially institutions with a focus on healthcare. To transport products domestically and internationally, a well-functioning network of transportation infrastructure including roads, airports, and railroads is an essential requirement.

article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

One reason for this growth is an increasing demand for personalized healthcare technologies as patients look for advances in how healthcare is delivered following the pandemic. NovaXS is on a mission to simplify the medication self-administration process and improve remote healthcare adherence. billion in 2030 at a CAGR of 9.2%.

article thumbnail

Diversity and inclusion in oncology clinical trials

Clarify Health

With the myriad of guidance and recommendations to boost diversity and inclusion in oncology trials, , biotech and pharmaceutical manufacturers are left to interpret the criteria and implement them through tangible action. J National Comprehensive Cancer Network. 2019;17(11):1309-1316. doi:10.6004/jnccn.2019.7321